Akzo Nobel India Financial Statements

Akzo Nobel India (AKZOINDIA) reported revenue of ₹35.99B in FY2026 with net income of ₹19.74B. Total assets stood at ₹37.95B and free cash flow was ₹462.00M.

Akzo Nobel India Income Statement

Hover the chart icon for year-over-year change.

FY 2025 – FY 2026

Item	Chart	2025	2026
Revenue		41.19B	35.99B
Cost of Rev. Cost of Revenue		-23.18B	-21.09B
Gross Profit		18.01B	14.90B
SGA Sales, General & Admin		-11.32B	-3.13B
Op. Income Operating Income		5.80B	4.33B
PBT Profit Before Tax		5.70B	23.66B
Net Income		4.29B	19.74B
Dil. Shares Diluted Shares		45.54M	45.52M
Diluted EPS		94.31	433.42

Figures in ₹ — millions (M), billions (B), trillions (T). EPS is earnings per share.

Understanding the Income Statement

The income statement shows Akzo Nobel India's revenue and expenses over a period. Revenue minus costs gives gross profit; after operating expenses, interest, and taxes, the remainder is net income. Diluted EPS divides net income by all shares that could exist if options and convertibles were exercised.

Akzo Nobel India Balance Sheet

Hover the chart icon for year-over-year change.

FY 2025 – FY 2026

Item	Chart	2025	2026
Curr. assets Total current assets		16.72B	17.87B
Non-curr. assets Total non-current assets		12.31B	20.08B
Total assets		29.03B	37.95B
Curr. liabilities Total current liabilities		14.50B	11.43B
Non-curr. liab. Total non-current liabilities		1.23B	2.01B
Total liabilities		15.73B	13.44B
Total equity		13.30B	24.52B
Total liab. & eq. Total liabilities & equity		29.03B	37.95B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding the Balance Sheet

The balance sheet captures Akzo Nobel India's financial position at a point in time — what it owns (assets), what it owes (liabilities), and the residual value to shareholders (equity). Total assets always equals total liabilities plus equity.

Akzo Nobel India Cash Flow Statement

Hover the chart icon for year-over-year change.

FY 2025 – FY 2026

Item	Chart	2025	2026
Net Income		5.70B	23.66B
Operating CF Cash flow Operating Activities		3.11B	932.00M
Capex Investments in PPE		-1.07B	-470.00M
Investing CF Cash flow Investing Activities		1.23B	8.04B
Dividend Paid		-4.33B	-8.47B
Financing CF Cash flow Financing Activities		-4.60B	-8.75B
Cash (start) Cash at beginning of period		2.74B	2.48B
Cash (end) Cash at end of period		2.48B	2.70B
FCF Free Cash Flow		2.05B	462.00M

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding Cash Flow

The cash flow statement tracks how Akzo Nobel India's cash moves through operations, investing, and financing activities. Free cash flow — operating cash minus capital expenditure — shows what is available to return to shareholders.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2026